Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Cited by (1,000)

Items 901–1,000 of 1,000

1. Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy
   Lei Yao, Xiao-Long Zao, Xiao-Fei Pan, Hao-Gang Zhang, Fu-Jing Wang, Peng-Fei Qiao · 2022 · Journal of Chemotherapy
2. Advances in the use of 3D colorectal cancer models for novel drug discovery
   Ana Baião, Sofia Dias, Ana Francisca Soares, Catarina Leite Pereira, Carla Oliveíra, Bruno Filipe Carmelino Cardoso Sarmento · 2022 · Expert Opinion on Drug Discovery
3. Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma
   Bingran Wang, Yizheng Xue, Wei Zhai · 2022 · Frontiers in Immunology
4. Remodelling and Improvements in Organoid Technology to Study Liver Carcinogenesis in a Dish
   Umesh Tharehalli, Michael Svinarenko, André Lechel · 2019 · Stem Cells International
5. Characterization of HMGB1/2 Interactome in Prostate Cancer by Yeast Two Hybrid Approach: Potential Pathobiological Implications
   Aída Barreiro-Alonso, María Cámara-Quílez, Martín Salamini-Montemurri, Mónica Lamas Maceiras, Ángel Vizoso‐Vázquez, Esther M. Rodriguez-Belmonte, María Quindós Varela, Olaia A. Martínez-Iglesias, Angélica Figueroa, M. Esperanza Cerdán · 2019 · Cancers
6. Tumor in 3D: In Vitro Complex Cellular Models to Improve Nanodrugs Cancer Therapy
   Soraia Fernandes, Marco Cassani, Stefania Pagliari, Petr Filipenský, Francesca Cavalieri, Giancarlo Forte · 2020 · Current Medicinal Chemistry
7. A novel 4D cell culture mimicking stomach peristalsis altered gastric cancer spheroids growth and malignance
   Juzhi Zhao, Ruiqi L. Wang, Jinyu Zhang, Yufang Zhao, Shupei Qiao, Thomas Crouzier, Hongji Yan, Weiming Tian · 2021 · Biofabrication
8. Value of Organoids from Comparative Epithelia Models.
   Julia Schwarz, Hugo R. de Jonge, John N. Forrest · 2015 · PubMed Central
9. Patient-derived tumor organoids: advances, applications, and future directions in biomedical research
   Ahmet Acar · 2026 · Frontiers in Medicine
10. Identification of gene-phenotype connectivity associated with flavanone naringenin by functional network analysis
    Suhong Fu, Yongqun Zhang, Jing Shi, Doudou Hao, Pengfei Zhang · 2019 · PeerJ
11. An Overview of Current Alternative Models for Use in the Context of Prostate Cancer Research
    Elisabete Nascimento-Gonçalves, Rita M. Ferreira, Paula A. Oliveira, Bruno Colaço · 2020 · Alternatives to Laboratory Animals
12. Focus on the road to modelling cardiomyopathy in muscular dystrophy
    Francesco Canonico, Maila Chirivì, Fabio Maiullari, Marika Milan, Roberto Rizzi, Alessandra Arcudi, Mattía Galli, Marika Pane, Aoife Gowran, Giulio Pompilio et al. · 2021 · Cardiovascular Research
13. Translational and Clinical Relevance of PDX‐Derived Organoid Models in Oncology Drug Discovery and Development
    Rajendra Kumari, Xiaoxi Xu, Henry Li · 2022 · Current Protocols
14. Preclinical patient‐derived modeling of castration‐resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease
    Mohamed E. Elsesy, Su Jung Oh‐Hohenhorst, Christoph Oing, Alicia Eckhardt, Susanne Burdak‐Rothkamm, Malik Alawi, Christian Müller, Ulrich Schüller, Tobias Maurer, Gunhild v. Amsberg et al. · 2023 · Molecular Oncology
15. Organoids as an Enabler of Precision Immuno-Oncology
    Junzhe Zhao, Antoinette Shui Wen Fong, See Voon Seow, Han Chong Toh · 2023 · Cells
16. Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability
    Louisa Nelson, Bethany M. Barnes, Anthony Tighe, Samantha Littler, Camilla Coulson‐Gilmer, Anya Golder, Sudha N. Desai, Robert David Morgan, Joanne C. McGrail, Stephen S. Taylor · 2023 · Chromosome Research
17. Establishment of a novel overlay culture method that enables immune response assessment using gastric cancer organoids
    Hiroshi Ota, Kazuaki Tanabe, Yoshihiro Saeki, Yuki Takemoto, Emi Chikuie, Yuka Tanaka, Naoya Sakamoto, Hideki Ohdan · 2023 · Heliyon
18. LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy
    Shu Ning, Cameron M. Armstrong, Enming Xing, Amy Rose Leslie, Richard Y. Gao, Masuda Sharifi, Zachary A. Schaaf, Wei Lou, Xiangrui Han, Desiree H. Xu et al. · 2024 · Cancer Research
19. Interpretation of the past, present, and future of organoid technology: an updated bibliometric analysis from 2009 to 2024
    Baozhen Qu, Qiang Mu, Huanhuan Bi, Yuxian Chen, Qitang Wang, Xuezhen Ma, Linlin Lu · 2024 · Frontiers in Cell and Developmental Biology
20. Patient-Derived Organoid Models for NKT Cell-Based Cancer Immunotherapy
    Pablo A. Palacios, Iván Flores, Lucas Cereceda, Francisco F. Otero, Marioly Müller, Priscilla Brebi, Héctor R. Contreras, Leandro J. Carreño · 2025 · Cancers
21. Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine
    Cory Michael Hugen, Daniel E. Zainfeld, Amir Goldkorn · 2017 · Frontiers in Oncology
22. Treatment for Non-Small-Cell Lung Cancer and Circulating Tumor Cells
    Joel Mason, Benjamin J. Blyth, Michael Patrick MacManus, Olga A. Martin · 2017 · Lung Cancer Management
23. Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells
    Huensuk Kim, Christoph Schaniel · 2018 · Frontiers in Immunology
24. Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing
    Naveen Ramesh, Emi Sei, Pei Ching Tsai, Shanshan Bai, Yuehui Zhao, Patricia Troncoso, Paul Gettys Corn, Christopher J. Logothetis, Amado J. Zurita, Nicholas E. Navin · 2020 · Genome biology
25. Future Match Making: When Pediatric Oncology Meets Organoid Technology
    Virginie Barbet, Laura Broutier · 2021 · Frontiers in Cell and Developmental Biology
26. Establishment of Functional Liver Spheroids From Human Hepatocyte-Derived Liver Progenitor-Like Cells for Cell Therapy
    Wenming Liu, Xu Zhou, Cai–Yang Chen, Dong-Dong Lv, Weijian Huang, Yuan Peng, Hongping Wu, Yi Chen, Dan Tang, Lina Guo et al. · 2021 · Frontiers in Bioengineering and Biotechnology
27. Three-Dimensional Cell Culture Systems in Pediatric and Adult Brain Tumor Precision Medicine
    Nicole C. Riedel, Flavia W. de Faria, Amelie Alfert, Jan M. Bruder, Kornelius Kerl · 2022 · Cancers
28. When Prostate Cancer Circulates in the Bloodstream
    Virginie Vlaeminck‐Guillem · 2015 · Diagnostics
29. Genomics Study of Gastric Cancer and Its Molecular Subtypes
    Siu Tsan Yuen, Suet Yi Leung · 2016 · Advances in experimental medicine and biology
30. Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
    Susan Kochall, May-Linn Thepkaysone, Sebastián A. García, Alexander M. Betzler, Jürgen Weitz, Christoph Reißfelder, Sebastian Schölch · 2017 · Journal of Visualized Experiments
31. Body-on-a-Chip: Regenerative Medicine for Personalized Medicine
    Aleksander Skardal, Thomas D Shupe, Anthony Atala · 2018 · Elsevier eBooks
32. Thread as a Low-Cost Material for Microfluidic Assays on Intact Tumor Slices
    Maxwell Rumaner, Lisa F. Horowitz, Avital Ovadya, Albert Folch · 2019 · Micromachines
33. Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
    Theresa M. Thole-Kliesch, Joern Toedling, Annika Sprüssel, Sebastian Pfeil, Larissa Savelyeva, David Capper, Clemens Messerschmidt, Dieter Beule, Stefanie Groeneveld‐Krentz, Cornelia Eckert et al. · 2019 · International Journal of Cancer
34. Liver Buds and Liver Organoids: New Tools for Liver Development, Disease and Medical Application
    Fanhong Zeng, Yue Zhang, Xu Han, Jun Weng, Yi Gao · 2019 · Stem Cell Reviews and Reports
35. miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
    Markus Krebs, Christoph Behrmann, Charis Kalogirou, Ioannis Sokolakis, Susanne Kneitz, Marianna Kruithof‐de Julio, Eugenio Zoni, Anne Rech, Bastian Schilling, Hubert R Kübler et al. · 2019 · BioMed Research International
36. Challenges, applications and future directions of precision medicine in prostate cancer – the role of organoids and patient‐derived xenografts
    Andre Joshi, Matthew J. Roberts, Saeid Alinezhad, Elizabeth D. Williams, Ian Vela · 2020 · British Journal of Urology
37. IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation
    Yipeng Xu, Gabriela Páchniková, He Wang, Yaoyao Wu, Dorothea Przybilla, Reinhold Schäfer, Zihao Chen, Shaoxing Zhu, Ulrich Keilholz · 2022 · Biomolecules and Biomedicine
38. Bioprinting of patient-derived heterogeneous renal cell carcinoma organoids for personalized therapy
    Shuangshuang Mao, Ruiyang Xie, Jianzhong Shou, Yuan Pang, Wei Yan Sun · 2025 · Biofabrication
39. Multiscale Construction, Evaluation, and Application of Organoids
    Wenzhong Ma, Zhenglin Dong, Zhu'anzhen Zheng, Long Bai, Xingcai Zhang, Jiacan Su · 2025 · Advanced Science
40. The establishment of kidney cancer organoid line in drug testing
    Ryan Tsz‐Hei Tse, Christine Yim‐Ping Wong, Xiaofan Ding, Carol Ka‐Lo Cheng, Chit Chow, Ronald Chan, Joshua Hoi-Yan Ng, Victor Wai‐Lun Tang, Peter Ka‐Fung Chiu, Jeremy Yuen‐Chun Teoh et al. · 2024 · Cancer Medicine
41. Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening
    Zhenjie Yang, Jun Qing Yu, Chi Chun Wong · 2024 · Cells
42. Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia
    Michele Stella, Giorgio Ivan Russo, Rosario Leonardi, Daniela Carcò, Giuseppe Gattuso, Luca Falzone, Carmen Ferrara, Angela Caponnetto, Rosalia Battaglia, Massimo Libra et al. · 2024 · International Journal of Molecular Sciences
43. Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors
    Marjolein M G Kes, Francisco Morales-Rodriguez, Esther A. Zaal, Terezinha Maria de Souza, Natalie Proost, Marieke van de Ven, Marry M. van den Heuvel‐Eibrink, Jeroen W. A. Jansen, Celia R. Berkers, Jarno Drost · 2024 · Cell Reports Medicine
44. An organoid library of human esophageal squamous cell carcinomas (ESCCs) uncovers the chemotherapy-resistant ESCC features
    Shunsaku Nakagawa, Taku Sato, Eriko Ohashi, Mihoko Kajita, Fuyuki Miya, Kouhei Yamamoto, Hiroki Yotsumata, Kazuya Yamaguchi, Yasuaki Nakajima, Akinori Miura et al. · 2025 · Communications Biology
45. Multicenter study correlating molecular characteristics and clinical outcomes of cancer cases with patient-derived organoids
    Paloma Navarro, Tatiana P. Grazioso, Arántzazu Barquín, Maria Barba, Mónica Yagüe, Carlos Millán, Irene López, Elena Sevillano, Miguel Quiralte, Paloma Fernández et al. · 2025 · Journal of Experimental & Clinical Cancer Research
46. Bioluminescence-mediated longitudinal monitoring of adipose-derived stem cells in a large mammal ex vivo organ culture
    Mirte Peeters, Sjoerd van Rijn, Pieter‐Paul A. Vergroesen, Cornelis P. L. Paul, David P. Noske, William Peter Vandertop, Thomas D. Wurdinger, Marco N. Helder · 2015 · Scientific Reports
47. Cell-free and circulating tumor cell–based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?
    David Tomoaki Miyamoto, Richard J. Lee · 2016 · Urologic Oncology Seminars and Original Investigations
48. iCTC drug resistance (CDR) Testing ex vivo for evaluation of available therapies to treat patients with epithelial ovarian cancer
    Michael L. Pearl, Huan Dong, Qiang Zhao, Shaun Tulley, Marlo Dombroff, Wen‐Tien Chen · 2017 · Gynecologic Oncology
49. Microfluidics Fabrication of Soft Microtissues and Bottom‐Up Assembly
    Shaohua Ma, Nobina Mukherjee · 2018 · Advanced Biosystems
50. From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer.
    Chuan Yu, Kevin M. Hu, Daniel Nguyen, Zhu A. Wang · 2019 · PubMed Central
51. Tumor organoids to study gastroesophageal cancer: a primer
    Ramon U. Jin, Jason C. Mills · 2020 · Journal of Molecular Cell Biology
52. Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study
    Luca Nicosia, Filippo Alongi, Silvia Andreani, Ruggero Ruggieri, Borislav Chavdarov Rusev, Beatrice Mantoan, Rita Teresa Lawlor, Antonio Pea, Aldo Scarpa, Linda Agolli et al. · 2020 · Biomedicines
53. In Vivo Models for Prostate Cancer Research
    Robert Adamiecki, Anita Hryniewicz‐Jankowska, Maria Antonia Ortiz, Xiang Li, Baylee A. Porter, Imad S. Nsouli, Gennady Bratslavsky, Leszek Kotula · 2022 · Cancers
54. Functional hepatobiliary organoids recapitulate liver development and reveal essential drivers of hepatobiliary cell fate determination
    Juan He, Haoyue Cui, Xiaohan Shi, Qiqi Jin, Ximeng Han, Tiantian Han, Jiayin Peng, Shiwei Guo, Lei Zhang, Yun Zhao et al. · 2022 · Life Medicine
55. Self-Seeding Microwells to Isolate and Assess the Viability of Single Circulating Tumor Cells
    Kiki Andree, Fikri Abali, Lisa Oomens, Fiona R. Passanha, Joska Johannes Broekmaat, Jaco Kraan, Pauline A.J. Mendelaar, Stefan Sleijfer, Leon W.M.M. Terstappen · 2019 · International Journal of Molecular Sciences
56. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing
    Praveen Kumar Kujur, Bianca C. T. Flores, Naveen Ramalingam, Ludmilla Thomé Domingos Chinen, Stefanie S. Jeffrey · 2020 · Advances in experimental medicine and biology
57. EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer
    Victoria Foy, Colin R. Lindsay, Alexandra Carmel, Fabiola Fernández‐Gutiérrez, Matthew Krebs, Lynsey J.C. Priest, Mathew Carter, Harry J.M. Groen, T. Jeroen N. Hiltermann, Antonella De Luca et al. · 2021 · Translational Lung Cancer Research
58. Cancer patient-derived organoids: Novel models for the study of natural products
    Shuxin Liu, Renyun Zhang, Yachen Liu, Xian Lin, Jian Chen · 2025 · International Journal of Biological Sciences
59. Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic
    Iñaki Eguren‐Santamaría, Ignacio Melero, Inmaculada Rodríguez, Ignacio Ortego, María Armero, Felipe Gálvez‐Cancino, Álvaro López‐Janeiro, Carlos E. de Andrea, Miguel F. Sanmamed · 2025 · Journal for ImmunoTherapy of Cancer
60. Using the Microwell-mesh to culture microtissues in vitro and as a carrier to implant microtissues in vivo into mice
    Melissa E. Monterosso, Kathryn Futrega, William B. Lott, Ian Vela, Elizabeth D. Williams, Michael Robert Doran · 2021 · Scientific Reports
61. Phytotherapy in Prostatitis: a Review on the Most Important Medicinal Plants Affecting Prostatitis in Iranian Ethnobotanical Documents
    Shaima Rabeea Banoon, Mohammad Narimani-Rad, Alireza Lotfi, Samira Shokri, Saber Abbaszadeh, Sedef Özliman · 2021 · Plant Biotechnology Persa
62. New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
    Vittoria Rago, Anna Perri, Silvia Di Agostino · 2023 · Biomedicines
63. Defining the challenges and opportunities for using patient‐derived models in prostate cancer research
    William Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, Nicolás Anselmino, Nathalie Bock, Nicholas Choo, Ashlee K. Clark, Ilsa M. Coleman, Robin Dolgos, Alison M. Ferguson et al. · 2024 · The Prostate
64. Exploring tumor organoids for cancer treatment
    Hairong Jin, Qian Yang, Jing Yang, Fangyan Wang, Jiayin Feng, Lanjie Lei, Minghai Dai · 2024 · APL Materials
65. Proteomic and phosphoproteomic landscape of localized prostate cancer unveils distinct molecular subtypes and insights into precision therapeutics
    Zengming Wang, Haolan Yu, Wei Bao, Min Qu, Yan Wang, Liandong Zhang, Xubing Liu, Chen Liu, Miaoxia He, Jing Li et al. · 2024 · Proceedings of the National Academy of Sciences
66. Exploring human pancreatic organoid modelling through single-cell RNA sequencing analysis
    Alessandro Cherubini, Francesco Rusconi, Roberta Piras, Kaja Nicole Wächtershäuser, Marta Dossena, Mario Barilani, Cecilia Mei, Lotta Hof, Valeria Sordi, Francesco Pampaloni et al. · 2024 · Communications Biology
67. MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy
    Keisuke Shigeta, Tatsuaki Daimon, Hiroshi Hongo, Sheng‐Yu Ku, Hiroki Ozawa, Naoki Haratake, Atsushi Fushimi, Ayako Nakashoji, Atrayee Bhattacharya, Shinkichi Takamori et al. · 2025 · JCI Insight
68. The Role of Organoids in Advancing Colorectal Cancer Research: Insights and Future Directions
    Zahra Heydari, Rex Devasahayam Arokia Balaya, Gobinda Sarkar, Lisa Boardman · 2025 · Cancers
69. Dynamic differences between DNA damage repair responses in primary tumors and cell lines
    Collin Gilbreath, Shihong Ma, Lan Yu, Rajni Sonavane, Carlos M. Roggero, Anvita Devineni, Ryan J. Mauck, Neil Bipinchandra Desai, Aditya Bagrodia, Ralf Kittler et al. · 2020 · Translational Oncology
70. Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer
    Krastan B. Blagoev, Roumen Borilov Iordanov, Mengxi Zhou, Tito Fojo, Susan Elaine Bates · 2021 · Oncotarget
71. Modeling colorectal cancers using multidimensional organoids
    Ibrahim M. Sayed, Amer Ali Abd El‐Hafeez, Priti Prasanna Maity, Soumita Das, Pradipta Ghosh · 2021 · Advances in cancer research
72. Next-Generation Human Liver Models for Antimalarial Drug Assays
    Kasem Kulkeaw · 2021 · Antibiotics
73. Alternative Models in Biomedical Research: In Silico, In Vitro, Ex Vivo, and Nontraditional In Vivo Approaches
    Jinping Gan, Brad N. Bolon, Terry Van Vleet, Charles E. Wood · 2021 · Elsevier eBooks
74. ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation
    Marco Lorenzoni, Dario De Felice, Giulia Beccaceci, Giorgia Di Donato, Veronica Foletto, Sacha Genovesi, Arianna Bertossi, Francesco Cambuli, Francesca Lorenzin, Aurora Savino et al. · 2022 · Cancer Letters
75. Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?
    Yanyun Gao, Marianna Kruithof‐de Julio, Ren‐Wang Peng, Patrick Dorn · 2022 · Cancers
76. Urological cancer organoids, patients' avatars for precision medicine: past, present and future
    Haotian Chen, Wentao Zhang, Niraj Maskey, Fuhan Yang, Zongtai Zheng, Cheng Li, Ruiliang Wang, Pengfei Wu, Shiyu Mao, Junfeng Zhang et al. · 2022 · Cell & Bioscience
77. TMEM158 expression is negatively regulated by AR signaling and associated with favorite survival outcomes in prostate cancers
    Jian Huang, Wang Liu, Da Zhang, Biyun Lin, Benyi Li · 2022 · Frontiers in Oncology
78. Organoids as a tool in drug discovery and patient-specific therapy for head and neck cancer
    Aaron J. Done, Andrew C. Birkeland · 2023 · Cell Reports Medicine
79. Patient derived xenografts as models for head and neck cancer
    Km Nitschinsk, Adi Idris, Nigel A.J. McMillan · 2018 · Cancer Letters
80. Epigenetic Process Monitoring in Live Cultures with Peptide Biosensors
    Nur P. Damayanti, Kevin Buno, Sherry L. Voytik Harbin, Joseph Irudayaraj · 2019 · ACS Sensors
81. Biopsia líquida y cáncer de próstata. Evidencia actual aplicada a la clínica
    Ignacio Puche Sanz, Alba Rodríguez Martínez, M. Carmen Garrido-Navas, Inmaculada Robles‐Fernandez, Fernando Vázquez‐Alonso, María Jesús Álvarez-Cubero, J.A. Lorente-Acosta, M.J. Serrano-Fernández, Jose Manuel Cozar-Olmo · 2019 · Actas Urológicas Españolas
82. “Tissues in a Dish”: A Review of Organoids in Plastic Surgery
    Malini S. Chinta, Heather Elizabeth desJardins-Park, Derrick C. Wan, Michael Thornton Longaker · 2020 · Plastic & Reconstructive Surgery Global Open
83. Clinical value and influencing factors of establishing stomach cancer organoids by endoscopic biopsy
    Jie Li, Yan Chen, Yingyi Zhang, Xiaobo Peng, Meihong Wu, Ling Chen, Xianbao Zhan · 2022 · Journal of Cancer Research and Clinical Oncology
84. Organoids—a better model for prostate cancer
    Robert Phillips · 2014 · Nature Reviews Urology
85. Cancer stem cell plasticity in shaping drug resistance landscapes in prostate cancer
    Xiaoyu Zhang, Xiaoqing Zhang, Qing Bao, Rong Li, Xinpei Deng, Jingna Cao, Huan Wang, Dong Chen, Yutian Zou, Hailin Tang · 2025 · Journal of Advanced Research
86. Tissue-specific cancer stem/progenitor cells: Therapeutic implications
    Amani Yehya, Joe Youssef, Sana Hachem, Jana Ismael, Wassim G. Abou-Kheir · 2023 · World Journal of Stem Cells
87. Organoids derived from metastatic cancers: Present and future
    Xuejing Zheng, Xinxin Zhang, Shengji Yu · 2024 · Heliyon
88. Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review
    Aliakbar Ebrahimi, Güntülü Ak, Ceren Özel, Hüseyin İzgördü, Hamed Ghorbanpoor, Shabir Hassan, Hüseyin Avcı, Muzaffer Metintaş · 2024 · ACS Pharmacology & Translational Science
89. Key considerations for a prostate cancer mRNA vaccine
    Guanjie Lin, Ahmed Elkashif, Chayanika Saha, Jonathan A. Coulter, Nicholas Dunne, Helen O. McCarthy · 2025 · Critical Reviews in Oncology/Hematology
90. Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer
    Tao Ding, Lina He, Guo-Wen Lin, Lei Xu, Yanjun Zhu, Xinan Wang, Xuefei Liu, Jianming Guo, Fanghong Lei, Zhixiang Zuo et al. · 2025 · Chinese Journal of Cancer Research
91. Applications and challenges of patient-derived organoids in hepatobiliary and pancreatic cancers
    Jia-Wei Hu, Yanzhi Pan, Xiaoxiao Zhang, Jiangtao Li, Yun Jin · 2025 · World Journal of Gastroenterology
92. Engineering organoid microfluidic system for biomedical and health engineering: A review
    Yifan Xing, Junyu Liu, Xiaojie Guo, Haipeng Liu, Wen Zeng, Yi Wang, Chong Zhang, Yuan Lu, He Dong, Shaohua Ma et al. · 2020 · Chinese Journal of Chemical Engineering
93. Lineage plasticity in prostate cancer: Looking beyond intrinsic alterations
    Alison M. Ferguson, Mark A. Rubin · 2022 · Cancer Letters
94. Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes
    Shu Ning, Jinge Zhao, Alan Paul Lombard, Leandro Salati D'Abronzo, Amy Rose Leslie, Masuda Sharifi, Wei Lou, Chengfei Liu, Joy C. Yang, Christopher P. Evans et al. · 2022 · Communications Medicine
95. A 3D Perfusable Platform for In Vitro Culture of Patient Derived Xenografts
    Lindsey K. Sablatura, Kristin M. Bircsak, Peter D.A. Shepherd, Madhavi Bathina, Karla C. S. Queiroz, Mary C. Farach‐Carson, Rick A. Kittles, Pamela E. Constantinou, Anthony D. Saleh, Nora Maria Navone et al. · 2022 · Advanced Healthcare Materials
96. Organoids: approaches and utility in cancer research
    Bing‐Rui Zhou, Zhiwei Feng, Jun Xu, Jun Xie · 2023 · Chinese Medical Journal
97. Effective Treatment for Recurrent Ovarian Cancer Guided by Drug Sensitivity from Ascites-Derived Organoid: A Case Report
    Wanyi Chen, Po-Han Fang, Bin Zheng, Yue Liang, Yiwen Mao, Xuefeng Jiang, Qiong-Lan Tang · 2023 · International Journal of Women s Health
98. Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer
    Verneri Virtanen, Kreetta Paunu, Antti Kukkula, Saana Niva, Ylva Junila, Mervi Toriseva, Terhi Jokilehto, Sari Mäkelä, Riikka Huhtaniemi, Matti H. POUTANEN et al. · 2023 · Oncogenesis
99. Liver organoids and their application in liver cancer research
    Xinyu Song, Kaifei Hou, Hongyan Zhou, Jingyi Yang, Ting Cao, Jiayu Zhang · 2023 · Regenerative Therapy
100. In vitro models of cancer
     Boussommier-Calleja, Alexandra · 2020 · Bioengineering Innovative Solutions for Cancer